[2,3-dihydro-1H-inden-5-yl-(3-methoxypyrazin-2-yl)methyl]hydrazine

C15H18N4O — CID 105332650

IUPAC[2,3-dihydro-1H-inden-5-yl-(3-methoxypyrazin-2-yl)methyl]hydrazine
SMILESCOc1nccnc1C(NN)c1ccc2c(c1)CCC2
InChIInChI=1S/C15H18N4O/c1-20-15-14(17-7-8-18-15)13(19-16)12-6-5-10-3-2-4-11(10)9-12/h5-9,13,19H,2-4,16H2,1H3
InChIKeyLJSGDUZSPVOVKM-UHFFFAOYSA-N
MW270.34 g/mol
LogP1.53
Rot. Bonds4

About [2,3-dihydro-1H-inden-5-yl-(3-methoxypyrazin-2-yl)methyl]hydrazine

[2,3-dihydro-1H-inden-5-yl-(3-methoxypyrazin-2-yl)methyl]hydrazine (PubChem CID 105332650) has the molecular formula C15H18N4O and a molecular weight of 270.34 g/mol. Its IUPAC name is [2,3-dihydro-1H-inden-5-yl-(3-methoxypyrazin-2-yl)methyl]hydrazine.

Molecular Properties

Compound Name[2,3-dihydro-1H-inden-5-yl-(3-methoxypyrazin-2-yl)methyl]hydrazine
PubChem CID105332650
Molecular FormulaC15H18N4O
Molecular Weight270.34 g/mol
Exact Mass270.15
IUPAC Name[2,3-dihydro-1H-inden-5-yl-(3-methoxypyrazin-2-yl)methyl]hydrazine
SMILESCOc1nccnc1C(NN)c1ccc2c(c1)CCC2
InChIInChI=1S/C15H18N4O/c1-20-15-14(17-7-8-18-15)13(19-16)12-6-5-10-3-2-4-11(10)9-12/h5-9,13,19H,2-4,16H2,1H3
InChIKeyLJSGDUZSPVOVKM-UHFFFAOYSA-N
XLogP1.53
TPSA73.06 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds4
Heavy Atoms20
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500270.34
LogP ≤ 51.53
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydrazine', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze [2,3-dihydro-1H-inden-5-yl-(3-methoxypyrazin-2-yl)methyl]hydrazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

[(3,4-dimethoxyphenyl)-(3-methoxypyrazin-2-yl)methyl]hydrazine
CID 105192205
[(3-bromo-4-methylphenyl)-(3-methoxypyrazin-2-yl)methyl]hydrazine
CID 105332597
[(3-bromo-5-methylphenyl)-(3-methoxypyrazin-2-yl)methyl]hydrazine
CID 105332579
[[4-(difluoromethoxy)phenyl]-(3-methoxypyrazin-2-yl)methyl]hydrazine
CID 105332626
[2,3-dihydro-1H-inden-5-yl-(1-methylimidazol-2-yl)methyl]hydrazine
CID 105308266
1-(2,3-dihydro-1-benzofuran-5-yl)-1-(3-methoxypyrazin-2-yl)-N-methylmethanamine
CID 105031866
[(3-methoxypyrazin-2-yl)-pyrimidin-2-ylmethyl]hydrazine
CID 105203713
[2,3-dihydro-1H-inden-5-yl-(2-fluoro-3-methoxyphenyl)methyl]hydrazine
CID 105329340
[2,3-dihydro-1H-inden-5-yl-(4-iodophenyl)methyl]hydrazine
CID 114195243
[(3-methoxypyrazin-2-yl)-(2,4,6-trimethylphenyl)methyl]hydrazine
CID 105332641
[2,3-dihydro-1H-inden-5-yl-(2,6-dimethylphenyl)methyl]hydrazine
CID 114195251
1-(3,4-dimethylphenyl)-1-(3-methoxypyrazin-2-yl)-N-methylmethanamine
CID 105031923

Frequently Asked Questions

What is the IUPAC name of [2,3-dihydro-1H-inden-5-yl-(3-methoxypyrazin-2-yl)methyl]hydrazine?
The IUPAC name of [2,3-dihydro-1H-inden-5-yl-(3-methoxypyrazin-2-yl)methyl]hydrazine (CID 105332650) is [2,3-dihydro-1H-inden-5-yl-(3-methoxypyrazin-2-yl)methyl]hydrazine.
What is the SMILES notation for [2,3-dihydro-1H-inden-5-yl-(3-methoxypyrazin-2-yl)methyl]hydrazine?
The canonical SMILES for [2,3-dihydro-1H-inden-5-yl-(3-methoxypyrazin-2-yl)methyl]hydrazine is COc1nccnc1C(NN)c1ccc2c(c1)CCC2.
What is the InChIKey of [2,3-dihydro-1H-inden-5-yl-(3-methoxypyrazin-2-yl)methyl]hydrazine?
The InChIKey is LJSGDUZSPVOVKM-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H18N4O/c1-20-15-14(17-7-8-18-15)13(19-16)12-6-5-10-3-2-4-11(10)9-12/h5-9,13,19H,2-4,16H2,1H3.
What are the key properties of [2,3-dihydro-1H-inden-5-yl-(3-methoxypyrazin-2-yl)methyl]hydrazine?
[2,3-dihydro-1H-inden-5-yl-(3-methoxypyrazin-2-yl)methyl]hydrazine has a molecular weight of 270.34 g/mol, XLogP of 1.53, 4 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for [2,3-dihydro-1H-inden-5-yl-(3-methoxypyrazin-2-yl)methyl]hydrazine is sourced from PubChem (CID 105332650), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).